As of 1:16pm ET
| -0.44 / -1.08%|
The 30 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 42.78, with a high estimate of 52.35 and a low estimate of 32.00. The median estimate represents a +6.47% increase from the last price of 40.18.
The current consensus among 34 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.